102 related articles for article (PubMed ID: 7540662)
1. Phospholipase A2 down-regulates the affinity of [3H]AMPA binding to rat cortical membranes.
Dev KK; Honoré T; Henley JM
J Neurochem; 1995 Jul; 65(1):184-91. PubMed ID: 7540662
[TBL] [Abstract][Full Text] [Related]
2. Different effects of phospholipase A2 on agonist binding to hippocampal, cortical and recombinant homomeric alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
Dev KK; Honoré T; Henley JM
Neurosci Lett; 1998 Apr; 246(1):25-8. PubMed ID: 9622199
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of [3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections.
Nielsen EO; Johansen TH; Wätjen F; Drejer J
J Neurochem; 1995 Sep; 65(3):1264-73. PubMed ID: 7543932
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A2 enhances [3H]AMPA binding to a putative homomeric GluR-B receptor in the rat spinal cord.
Cruickshank AM; Henley JM
FEBS Lett; 1994 Feb; 339(1-2):168-70. PubMed ID: 7508865
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase A2-induced changes in AMPA receptor: an autoradiographic study.
Tocco G; Massicotte G; Standley S; Thompson RF; Baudry M
Neuroreport; 1992 Jun; 3(6):515-8. PubMed ID: 1382660
[TBL] [Abstract][Full Text] [Related]
6. Postnatal changes in AMPA receptor regulation by phospholipase A2 treatment of synaptic membranes: temporally differential effects on agonist and antagonist binding.
Massicotte G; Bernard J; Baudry M
Brain Res Dev Brain Res; 1992 Apr; 66(2):203-8. PubMed ID: 1351426
[TBL] [Abstract][Full Text] [Related]
7. The phospholipase A2 inhibitor bromophenacyl bromide prevents the depolarization-induced increase in [3H]AMPA binding in rat brain synaptoneurosomes.
Bernard J; Lahsaïni A; Baudry M; Massicotte G
Brain Res; 1993 Nov; 628(1-2):340-4. PubMed ID: 7508812
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus.
Chabot C; Gagné J; Giguère C; Bernard J; Baudry M; Massicotte G
Hippocampus; 1998; 8(3):299-309. PubMed ID: 9662143
[TBL] [Abstract][Full Text] [Related]
9. Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment.
McCoy L; Richfield EK; Cory-Slechta DA
J Neurochem; 1997 Dec; 69(6):2466-76. PubMed ID: 9375679
[TBL] [Abstract][Full Text] [Related]
10. Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment.
Massicotte G; Baudry M
Neurosci Lett; 1990 Oct; 118(2):245-8. PubMed ID: 2177177
[TBL] [Abstract][Full Text] [Related]
11. Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics.
Kurumaji A; Ishimaru M; Toru M
J Neurochem; 1992 Sep; 59(3):829-37. PubMed ID: 1379631
[TBL] [Abstract][Full Text] [Related]
12. AMPA receptor modulation in previously frozen mouse brain sections: opposite effects of calcium in the cortex and hippocampus.
Lapierre L; Valastro B; Miceli D; Massicotte G
Hippocampus; 2000; 10(6):645-53. PubMed ID: 11153710
[TBL] [Abstract][Full Text] [Related]
13. Multiple states of rat brain (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography.
Cha JH; Makowiec RL; Penney JB; Young AB
Mol Pharmacol; 1992 May; 41(5):832-8. PubMed ID: 1375315
[TBL] [Abstract][Full Text] [Related]
14. High-affinity binding sites for 125I-labelled pancreatic secretory phospholipase A2 in rat brain.
Dev KK; Foged C; Andersen H; Honoré T; Henley JM
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):120-6. PubMed ID: 9387871
[TBL] [Abstract][Full Text] [Related]
15. AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities.
Ménard C; Valastro B; Martel MA; Chartier E; Marineau A; Baudry M; Massicotte G
Hippocampus; 2005; 15(3):370-80. PubMed ID: 15630695
[TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA.
Ebert B; Madsen U; Lund TM; Lenz SM; Krogsgaard-Larsen P
Neurochem Int; 1994 Jun; 24(6):507-15. PubMed ID: 7526921
[TBL] [Abstract][Full Text] [Related]
17. Kainate binding to the AMPA receptor in rat brain.
Hall RA; Kessler M; Lynch G
Neurochem Res; 1994 Jun; 19(6):777-82. PubMed ID: 7520541
[TBL] [Abstract][Full Text] [Related]
18. Increasing binding affinity of agonists to glutamate receptors increases synaptic responses at glutamatergic synapses.
Shahi K; Baudry M
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6881-5. PubMed ID: 1379724
[TBL] [Abstract][Full Text] [Related]
19. Non-NMDA glutamate receptor antagonist 3H-CNOX binds with equal affinity to two agonist states of quisqualate receptors.
Honore T; Drejeŕ J; Nielsen EO; Nielsen M
Biochem Pharmacol; 1989 Oct; 38(19):3207-12. PubMed ID: 2573355
[TBL] [Abstract][Full Text] [Related]
20. Selective changes in AMPA receptors in rabbit cerebellum following classical conditioning of the eyelid-nictitating membrane response.
Hauge SA; Tracy JA; Baudry M; Thompson RF
Brain Res; 1998 Aug; 803(1-2):9-18. PubMed ID: 9729243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
